Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">Optimized ratio of drug and resin</td><td align="center" colspan="3">% Drug loading by resin activation</td></tr><tr class="thead"><td align="center">Acid</td><td align="center">Alkali</td><td align="center">Acid-alkali</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Kyron-T-104 (1 : 4)</td><td align="center">67.24</td><td align="center">48.32</td><td align="center">57.63</td></tr><tr><td align="left">Tulsion-412 (1 : 5)</td><td align="center">63.87</td><td align="center">43.19</td><td align="center">56.84</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Effect of resin activation on drug loading.

Journal of Pharmaceutics

tab2

Table 2

Table 2: Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization 

Table 2 | Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization 